• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非黑色素瘤皮肤癌的发病情况与临床分析。

The incidence and clinical analysis of non-melanoma skin cancer.

机构信息

Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, ul. Pabianicka 62, 93-513, Łódź, Poland.

Department of Bone Marrow Transplantation and Hematology-Oncology, Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.

出版信息

Sci Rep. 2021 Feb 22;11(1):4337. doi: 10.1038/s41598-021-83502-8.

DOI:10.1038/s41598-021-83502-8
PMID:33619293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7900109/
Abstract

Non-melanoma skin cancers (NMSCs) are the most common malignancies diagnosed in Caucasian populations. Basal cell carcinoma (BCC) is the most frequent skin cancer, followed by squamous cell carcinoma (SCC). Unfortunately, most European cancer registries do not record individual types of NMSC. To evaluate the incidence of primary BCCs and SCCs regarding age, sex, tumour site and tumour subtype to determine trends in epidemiology of both cancers. Retrospective analysis of BCCs and SCCs diagnosed and treated across seven sites in Poland from 1999 to 2019. We recorded 13,913 NMSCs occurring in 10,083 patients. BCC represented 85.2% of all cases. SCC patients were older than BCC patients (77.1 ± 11.3 years vs. 70.1 ± 12.3 years, p < 0.01). The nodular subtype was the most common subtype of BCC, followed by the superficial and infiltrative subtypes. The superficial BCC subtype was more common on photoprotected areas (p < 0.01), whereas the nodular BCC subtype occurred on the face (p < 0.01). The high-risk SCC subtypes were more common on face compared to low-risk SCC subtypes (p < 0.01). BCC and SCC are common malignancies developing at various ages and anatomical sites. These data underline the need for better registration policies regarding NMSC in order to improve prevention and treatment strategies for these tumours.

摘要

非黑色素瘤皮肤癌(NMSC)是白种人群中最常见的恶性肿瘤。基底细胞癌(BCC)是最常见的皮肤癌,其次是鳞状细胞癌(SCC)。不幸的是,大多数欧洲癌症登记处并不记录 NMSC 的具体类型。为了评估原发性 BCC 和 SCC 的发病率,按年龄、性别、肿瘤部位和肿瘤亚型进行评估,以确定这两种癌症的流行病学趋势。回顾性分析了波兰 7 个地区 1999 年至 2019 年期间诊断和治疗的 BCC 和 SCC。我们记录了 13913 例 NMSC,涉及 10083 名患者。BCC 占所有病例的 85.2%。SCC 患者比 BCC 患者年龄大(77.1±11.3 岁 vs. 70.1±12.3 岁,p<0.01)。结节型是 BCC 最常见的亚型,其次是浅表型和浸润型。浅表型 BCC 更常见于光保护部位(p<0.01),而结节型 BCC 则发生在面部(p<0.01)。高危 SCC 亚型比低危 SCC 亚型更常见于面部(p<0.01)。BCC 和 SCC 是常见的恶性肿瘤,发生在不同的年龄和解剖部位。这些数据强调了需要更好的 NMSC 登记政策,以改善这些肿瘤的预防和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/0f758e7a6386/41598_2021_83502_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/545c73aeae43/41598_2021_83502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/414f6fc5f3b2/41598_2021_83502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/83d5e52f8d4d/41598_2021_83502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/a0b7c8d3b8e9/41598_2021_83502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/2a10a80257ec/41598_2021_83502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/13bddce781fb/41598_2021_83502_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/0f758e7a6386/41598_2021_83502_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/545c73aeae43/41598_2021_83502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/414f6fc5f3b2/41598_2021_83502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/83d5e52f8d4d/41598_2021_83502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/a0b7c8d3b8e9/41598_2021_83502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/2a10a80257ec/41598_2021_83502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/13bddce781fb/41598_2021_83502_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372c/7900109/0f758e7a6386/41598_2021_83502_Fig7_HTML.jpg

相似文献

1
The incidence and clinical analysis of non-melanoma skin cancer.非黑色素瘤皮肤癌的发病情况与临床分析。
Sci Rep. 2021 Feb 22;11(1):4337. doi: 10.1038/s41598-021-83502-8.
2
Non-melanoma skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinicopathological characteristics.1990年至1999年间土耳其伊兹密尔的非黑色素瘤皮肤癌:人口统计学和临床病理特征
J Dermatol. 2003 Feb;30(2):123-31. doi: 10.1111/j.1346-8138.2003.tb00359.x.
3
Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma.非黑色素瘤皮肤癌——基底细胞癌和鳞状细胞癌患者的临床病理研究
Klin Onkol. 2017 Winter;31(1):40-45. doi: 10.14735/amko201840.
4
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.年龄、性别、种族和地理位置与美国基底细胞癌与皮肤鳞状细胞癌比率变化的关联。
JAMA Dermatol. 2020 Nov 1;156(11):1192-1198. doi: 10.1001/jamadermatol.2020.2571.
5
Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.电离辐射治疗后基底细胞癌和鳞状细胞癌的风险。皮肤癌预防研究小组。
J Natl Cancer Inst. 1996 Dec 18;88(24):1848-53. doi: 10.1093/jnci/88.24.1848.
6
Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.p16 蛋白在皮肤基底细胞癌中的表达:仍远未被充分理解。
Acta Dermatovenerol Croat. 2020 Jul;28(1):43-44.
7
Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.1978-2007 年丹麦非黑色素瘤皮肤癌发病率趋势:丹麦年轻女性发病率迅速上升。
Int J Cancer. 2010 Nov 1;127(9):2190-8. doi: 10.1002/ijc.25411.
8
Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.夏威夷考艾岛日本裔夏威夷人的非黑色素瘤皮肤癌:发病率报告。
J Am Acad Dermatol. 1995 Sep;33(3):422-6. doi: 10.1016/0190-9622(95)91387-4.
9
Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.荷兰基于人群队列中首次黑色素瘤、鳞状细胞癌和基底细胞癌后不同皮肤肿瘤组合的风险:1989-2009 年。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):382-389. doi: 10.1111/jdv.14587. Epub 2017 Oct 17.
10
Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.1980 年至 2019 年法国首例基底细胞癌的发病率和趋势:一项基于区域人群的登记研究。
Br J Dermatol. 2024 Sep 18;191(4):519-528. doi: 10.1093/bjd/ljae201.

引用本文的文献

1
Diagnostic Challenges and Influencing Factors in Non-Melanoma Skin Cancers: A Retrospective Analysis of Basal Cell Carcinoma and Squamous Cell Carcinoma Cases.非黑色素瘤皮肤癌的诊断挑战与影响因素:基底细胞癌和鳞状细胞癌病例的回顾性分析
Cancer Rep (Hoboken). 2025 Sep;8(9):e70332. doi: 10.1002/cnr2.70332.
2
Incidence, screening, and management of malignancies in liver transplant patients: A review.肝移植患者恶性肿瘤的发病率、筛查与管理:综述
World J Transplant. 2025 Sep 18;15(3):101046. doi: 10.5500/wjt.v15.i3.101046.
3
Bioactive Potential of Flower Extracts: Antidiabetic, Anti-Skin Aging, Cytotoxic, and Dihydroorotase-Inhibitory Activities.

本文引用的文献

1
Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study.基底鳞状细胞癌的临床和流行病学分析:多中心研究结果。
Sci Rep. 2020 Oct 28;10(1):18475. doi: 10.1038/s41598-020-72732-x.
2
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Merkel 细胞癌,1.2018 年版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Jun;16(6):742-774. doi: 10.6004/jnccn.2018.0055.
3
Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland.
花提取物的生物活性潜力:抗糖尿病、抗皮肤衰老、细胞毒性及二氢乳清酸酶抑制活性
Plants (Basel). 2025 Aug 19;14(16):2579. doi: 10.3390/plants14162579.
4
Trends in the incidence of nonmelanoma skin cancer of head, neck, and face in Southern Thailand.泰国南部头颈部及面部非黑素瘤皮肤癌的发病率趋势
Sci Rep. 2025 Aug 27;15(1):31636. doi: 10.1038/s41598-025-15653-x.
5
High-Frequency Basal Cell Carcinoma: Demographic, Clinical, and Histopathological Features in a Belgian Cohort.高频基底细胞癌:比利时队列中的人口统计学、临床和组织病理学特征
J Clin Med. 2025 Jul 2;14(13):4678. doi: 10.3390/jcm14134678.
6
Modelling the ageing dependence of cancer evolutionary trajectories.模拟癌症进化轨迹的衰老依赖性。
Nat Rev Cancer. 2025 Jul 10. doi: 10.1038/s41568-025-00838-3.
7
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies.西妥昔单抗在非黑色素瘤皮肤癌中的作用:临床证据与新兴策略综述
Curr Treat Options Oncol. 2025 Jul 9. doi: 10.1007/s11864-025-01335-3.
8
Efficacy, Safety, and Patient Reported Outcomes of Rhenium-Skin Cancer Therapy for Non-Melanoma Skin Cancer: 1-Year Results from the EPIC-Skin Study.铼治疗非黑色素瘤皮肤癌的疗效、安全性及患者报告结局:EPIC-Skin研究的1年结果
Adv Radiat Oncol. 2025 Apr 29;10(7):101802. doi: 10.1016/j.adro.2025.101802. eCollection 2025 Jul.
9
Epidemiology of Skin Diseases in Poland: Analysis of Prevalence and Risk Factors: A Cross-Sectional Study.波兰皮肤病流行病学:患病率及危险因素分析:一项横断面研究
Dermatol Ther (Heidelb). 2025 Jun 21. doi: 10.1007/s13555-025-01464-5.
10
Temporal trend in non-melanoma skin cancer mortality in China, 1992-2021: an analysis for the global burden of disease study 2021.1992 - 2021年中国非黑色素瘤皮肤癌死亡率的时间趋势:全球疾病负担研究2021的分析
Front Med (Lausanne). 2025 May 14;12:1495454. doi: 10.3389/fmed.2025.1495454. eCollection 2025.
基底细胞癌发病率趋势:对波兰中部人群的16年回顾性研究。
Postepy Dermatol Alergol. 2018 Feb;35(1):47-52. doi: 10.5114/ada.2018.73164. Epub 2018 Feb 19.
4
Anatomy of the Skin and the Pathogenesis of Nonmelanoma Skin Cancer.皮肤解剖与非黑色素瘤皮肤癌的发病机制
Facial Plast Surg Clin North Am. 2017 Aug;25(3):283-289. doi: 10.1016/j.fsc.2017.03.001. Epub 2017 May 30.
5
CARCINOSARCOMA OF SKIN (SARCOMATOID CARCINOMA) - A RARE NON-MELANOMA SKIN CANCER (CASE REVIEW).皮肤癌肉瘤(肉瘤样癌)——一种罕见的非黑色素瘤皮肤癌(病例回顾)。
Georgian Med News. 2017 Feb(263):7-10.
6
Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting.高危基底细胞癌亚型的分类:ONTRAC研究的经验以及病理报告的建议定义和指南
Pathology. 2016 Aug;48(5):395-7. doi: 10.1016/j.pathol.2016.05.005. Epub 2016 Jun 14.
7
Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.非黑色素瘤皮肤癌治疗共识:基底细胞癌,包括治疗方法的成本分析。
Dermatol Surg. 2015 May;41(5):550-71. doi: 10.1097/DSS.0000000000000296.
8
Differences in age and topographic distribution of the different histological subtypes of basal cell carcinoma, Taubaté (SP), Brazil.巴西圣保罗州陶巴特市基底细胞癌不同组织学亚型的年龄和地形分布差异。
An Bras Dermatol. 2013 Sep-Oct;88(5):726-30. doi: 10.1590/abd1806-4841.20132145.
9
Diagnostic concordance rates in the subtyping of basal cell carcinoma by different dermatopathologists.不同皮肤病理学家对基底细胞癌进行亚型分类时的诊断一致性率。
J Cutan Pathol. 2014 Jan;41(1):9-13. doi: 10.1111/cup.12256. Epub 2013 Nov 14.
10
Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas.波兰中部地区发展表浅性和结节性基底细胞癌的危险因素。
Arch Med Sci. 2010 Apr 30;6(2):270-5. doi: 10.5114/aoms.2010.13907.